Market Overview:
The global animal sedative market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for animal sedatives for various applications such as surgical, diagnosis, and clinical research studies. In addition, the growing awareness about animal welfare is also contributing to the growth of this market. Based on type, the global animal sedative market can be segmented into oral and parenteral segments. The oral segment is expected to dominate this market during the forecast period owing to its ease of use and low cost as compared to parenteral drugs. Based on application, the global animal sedative market can be divided into surgical, diagnosis, and clinical research studies segments.
Product Definition:
The term "animal sedative" is used to describe a drug or substance that is used to calm down or relax animals. Animal sedatives can be used to help calm and relax animals prior to surgery, during transport, or when they are being handled.
Oral:
Oral is a drug that is administered by mouth. It may be used to treat various disorders, such as epilepsy and anxiety. Oral sedative drugs are commonly used for inducing sleep; they are often referred to as sleeping pills or lullabies. They work by decreasing the activity of the brain's ascending reticular activating system, which causes wakefulness and alertness.
Parenteral:
Parenteral is a route of drug administration, which involves injecting the drug into the body. It can be oral or injectable. The most common routes of drug administration are oral and parenteral. Injectables are more popular as compared to oral drugs because they offer advantages such as quick absorption and high bioavailability (the amount of active ingredient that is actually absorbed by the body).
Application Insights:
The surgical segment dominated the global animal sedative market in 2017. The growth of this application can be attributed to an increase in pet ownership and a growing preference for pet surgeries. According to a study published by the American Pet Products Association, there were 78 million households owning pets as of 2016, which was a 2% rise from 2015. Moreover, according to the same source, around 68% of U.S households own at least two cats and over 35% own at least one dog while 10% have more than three dogs or cats at home.
Regional Analysis:
North America dominated the global animal sedative market in 2017. The growth is majorly attributed to the high prevalence of diseases such as insomnia, anxiety and stress-related disorders among pets in U.S., which has led to an increase in drug consumption. According to a survey conducted by Pet Leadership Council, approximately 60% of U.S households own dogs and it was found that 45% of them exhibited behavior associated with separation anxiety disorder while 80% were reported to bark incessantly or chew furniture excessively resulting into expensive damage.
Asia Pacific is expected witness lucrative growth over the forecast period owing to rising disposable income coupled with growing pet adoption trend especially among middle-class income groups who treat their pets like family members thus leading them into greater vulnerability for mental health issues such as separation anxiety disorder and obsessive compulsive disorder (OCD).
Growth Factors:
- Increasing demand for animal sedatives owing to the rise in companion animals
- Growing awareness about the benefits of animal sedatives among veterinarians and pet owners
- Rising number of veterinary clinics and hospitals across the globe
- Technological advancements in the field of animal sedatives
- Growing demand for natural and herbal animal sedatives
Scope Of The Report
Report Attributes
Report Details
Report Title
Animal Sedative Market Research Report
By Type
Oral, Parenteral
By Application
Surgical, Diagnosis, Clinical Research Studies
By Companies
Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Ceva Animal Health, Virbac, Orion Corporation, Dechra Pharmaceuticals, Ourofino Saude Animal
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
153
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Animal Sedative Market Report Segments:
The global Animal Sedative market is segmented on the basis of:
Types
Oral, Parenteral
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Surgical, Diagnosis, Clinical Research Studies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zoetis
- Boehringer Ingelheim
- Merck Animal Health
- Elanco Animal Health
- Ceva Animal Health
- Virbac
- Orion Corporation
- Dechra Pharmaceuticals
- Ourofino Saude Animal
Highlights of The Animal Sedative Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Parenteral
- By Application:
- Surgical
- Diagnosis
- Clinical Research Studies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Animal Sedative Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Animal sedatives are medications that are used to tranquilize animals. They can be used to treat a variety of conditions, including anxiety, fear, and aggression.
Some of the major players in the animal sedative market are Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Ceva Animal Health, Virbac, Orion Corporation, Dechra Pharmaceuticals, Ourofino Saude Animal.
The animal sedative market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Animal Sedative Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Animal Sedative Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Animal Sedative Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Animal Sedative Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Animal Sedative Market Size & Forecast, 2020-2028
4.5.1 Animal Sedative Market Size and Y-o-Y Growth
4.5.2 Animal Sedative Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral
5.2.2 Parenteral
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Surgical
6.2.2 Diagnosis
6.2.3 Clinical Research Studies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Animal Sedative Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Animal Sedative Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral
9.6.2 Parenteral
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Surgical
9.10.2 Diagnosis
9.10.3 Clinical Research Studies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral
10.6.2 Parenteral
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Surgical
10.10.2 Diagnosis
10.10.3 Clinical Research Studies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral
11.6.2 Parenteral
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Surgical
11.10.2 Diagnosis
11.10.3 Clinical Research Studies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral
12.6.2 Parenteral
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Surgical
12.10.2 Diagnosis
12.10.3 Clinical Research Studies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral
13.6.2 Parenteral
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Surgical
13.10.2 Diagnosis
13.10.3 Clinical Research Studies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Animal Sedative Market: Competitive Dashboard
14.2 Global Animal Sedative Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zoetis
14.3.2 Boehringer Ingelheim
14.3.3 Merck Animal Health
14.3.4 Elanco Animal Health
14.3.5 Ceva Animal Health
14.3.6 Virbac
14.3.7 Orion Corporation
14.3.8 Dechra Pharmaceuticals
14.3.9 Ourofino Saude Animal
